Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Sarcopenia: its assessment, etiology, pathogenesis, consequences and future|
Abellan Van Kan, G.
|Citation:||Journal of Nutrition, Health and Aging, 2008; 12(7):433-450|
|Y. Rolland, S. Czerwinski, G. Abellan Van Kan, J.E. Morley, M. Cesari, G. Onder, J. Woo, R. Baumgartner, F. Pillard, Y. Boirie, W.M.C. Chumlea, B. Vellas|
|Abstract:||Sarcopenia is a loss of muscle protein mass and loss of muscle function. It occurs with increasing age, being a major component in the development of frailty. Current knowledge on its assessment, etiology, pathogenesis, consequences and future perspectives are reported in the present review. On-going and future clinical trials on sarcopenia may radically change our preventive and therapeutic approaches of mobility disability in older people|
|Keywords:||Muscle, Skeletal; Humans; Muscular Atrophy; Exercise; Aging; Aged; Aged, 80 and over; Frail Elderly|
|Appears in Collections:||Medicine publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.